Apotheek Vichte: what changed
Two financial years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
Apotheek Vichte
Largest movements
- Stocks and contracts +€44,196
up €44,196 (+16.1%), from €274,711 to €318,907
- Receivables within one year +€33,929
up €33,929 (+14.4%), from €235,532 to €269,461
of which Trade receivables: +€47,707
- Cash -€26,186
down €26,186 (-6.7%), from €393,181 to €366,995
mainly Contributions, distributions and other (-€313,124) and Trade debts (-€55,307)
- Other debts +€111,509
up €111,509 (+55.2%), from €201,910 to €313,419
- Trade debts -€55,307
down €55,307 (-20.8%), from €266,073 to €210,766
- Gross operating margin +€130,220
up €130,220 (+27.2%), from €479,446 to €609,667
- Staff costs +€19,163
up €19,163 (+7.5%), from €255,179 to €274,342
From the 2024 result to the 2025 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Derived cash bridge
Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €1,085,561 | €1,136,032 | +€50,471 | +4.6% |
| Fixed assets | 21/28 | €170,645 | €163,993 | -€6,652 | -3.9% |
| Intangible fixed assets | 21 | €49,847 | €44,847 | -€5,000 | -10.0% |
| Tangible fixed assets | 22/27 | €112,798 | €103,905 | -€8,892 | -7.9% |
| Plant, machinery and equipment | 23 | €5,070 | €4,771 | -€299 | -5.9% |
| Furniture and vehicles | 24 | €8,450 | €11,102 | +€2,652 | +31.4% |
| Other tangible fixed assets | 26 | €99,277 | €88,032 | -€11,245 | -11.3% |
| Financial fixed assets | 28 | €8,000 | €15,241 | +€7,241 | +90.5% |
| Current assets | 29/58 | €914,916 | €972,039 | +€57,123 | +6.2% |
| Stocks and contracts in progress | 3 | €274,711 | €318,907 | +€44,196 | +16.1% |
| Stocks | 30/36 | €274,711 | €318,907 | +€44,196 | +16.1% |
| Amounts receivable within one year | 40/41 | €235,532 | €269,461 | +€33,929 | +14.4% |
| Trade receivables | 40 | €201,161 | €248,868 | +€47,707 | +23.7% |
| Other amounts receivable | 41 | €34,371 | €20,593 | -€13,778 | -40.1% |
| Cash at bank and in hand | 54/58 | €393,181 | €366,995 | -€26,186 | -6.7% |
| Deferred charges and accrued income | 490/1 | €11,493 | €16,676 | +€5,183 | +45.1% |
| Total equity and liabilities | 10/49 | €1,085,561 | €1,136,032 | +€50,471 | +4.6% |
| Equity | 10/15 | €582,642 | €583,314 | +€672 | +0.1% |
| Contributions | 10/11 | €262,000 | €262,000 | = | 0.0% |
| Reserves | 13 | €320,642 | €321,314 | +€672 | +0.2% |
| Tax-exempt reserves | 132 | €40,000 | €40,000 | = | 0.0% |
| Distributable reserves | 133 | €280,642 | €281,314 | +€672 | +0.2% |
| Profit (loss) carried forward | 14 | €0 | €0 | = | |
| Amounts payable | 17/49 | €502,919 | €552,718 | +€49,799 | +9.9% |
| Amounts payable after more than one year | 17 | €0 | - | = | |
| Financial debts | 170/4 | €0 | - | = | |
| Amounts payable within one year | 42/48 | €502,803 | €552,654 | +€49,851 | +9.9% |
| Current portion of amounts payable after more than one year | 42 | €913 | €0 | -€913 | -100% |
| Trade debts | 44 | €266,073 | €210,766 | -€55,307 | -20.8% |
| Suppliers | 440/4 | €266,073 | €210,766 | -€55,307 | -20.8% |
| Advances received on contracts in progress | 46 | €0 | €135 | +€135 | |
| Taxes, remuneration and social security | 45 | €33,906 | €28,333 | -€5,573 | -16.4% |
| Taxes | 450/3 | €15 | €342 | +€327 | +2,181% |
| Remuneration and social security | 454/9 | €33,891 | €27,991 | -€5,900 | -17.4% |
| Other amounts payable | 47/48 | €201,910 | €313,419 | +€111,509 | +55.2% |
| Accrued charges and deferred income | 492/3 | €116 | €64 | -€52 | -44.6% |
| Remuneration, social security and pensions | 62 | €255,179 | €274,342 | +€19,163 | +7.5% |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | €21,595 | €21,032 | -€563 | -2.6% |
| Write-downs on stocks, contracts in progress and trade receivables: additions (reversals) | 631/4 | €0 | - | = | |
| Other operating charges | 640/8 | €1,094 | €1,304 | +€211 | +19.3% |
| Gross operating margin | 9900 | €479,446 | €609,667 | +€130,220 | +27.2% |
| Operating profit (loss) | 9901 | €201,578 | €312,988 | +€111,410 | +55.3% |
| Financial income | 75/76B | €2,507 | €2,574 | +€67 | +2.7% |
| Recurring financial income | 75 | €2,507 | €2,574 | +€67 | +2.7% |
| Financial charges | 65/66B | €410 | €304 | -€106 | -25.8% |
| Recurring financial charges | 65 | €410 | €304 | -€106 | -25.8% |
| Profit (loss) for the period before taxes | 9903 | €203,676 | €315,258 | +€111,582 | +54.8% |
| Income taxes | 67/77 | €949 | €1,461 | +€513 | +54.0% |
| Profit (loss) for the period | 9904 | €202,727 | €313,796 | +€111,069 | +54.8% |
| Profit (loss) for the period to be appropriated | 9905 | €202,727 | €313,796 | +€111,069 | +54.8% |
Source: filed annual accounts (NBB), financial years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 28 October 2026 via checked.be.